Loading...
XSHE
300981
Market cap932mUSD
Dec 05, Last price  
15.43CNY
1D
1.45%
1Q
10.61%
IPO
-71.71%
Name

Zhonghong Pulin Medical Products Co Ltd

Chart & Performance

D1W1MN
XSHE:300981 chart
P/E
P/S
2.68
EPS
Div Yield, %
3.24%
Shrs. gr., 5y
0.31%
Rev. gr., 5y
15.98%
Revenues
2.46b
+16.69%
550,611,138585,048,800604,083,100710,080,600951,153,298967,534,1271,170,814,0404,778,406,8724,909,310,9361,572,568,5132,105,249,6072,456,650,714
Net income
-87m
L-33.42%
3,035,80724,917,20042,313,40038,214,70065,010,53556,669,36289,266,0182,663,518,7162,341,903,87966,916,009-130,870,579-87,128,895
CFO
184m
+30.73%
13,365,927133,333,00092,230,044102,368,25296,027,72223,766,227184,382,5612,719,677,0592,362,497,606106,707,621140,676,906183,912,342
Dividend
Jun 27, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhonghong Pulin Medical Products Co., Ltd. researches, develops, manufactures, and sells plastic gloves. Its products include disposable vinyl and nitrile gloves for use in the medical, food service, and electronic industries. The company was founded in 2010 and is based in Tangshan, China. Zhonghong Pulin Medical Products Co., Ltd. operates as a subsidiary of Zhonghong Pulin Group Co., Ltd.
IPO date
Apr 27, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT